Home > National Drug Code (NDC) > Triamterene and Hydrochlorothiazide

Triamterene and Hydrochlorothiazide - 55289-725-30 - (Triamterene and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Triamterene and Hydrochlorothiazide

Product NDC: 55289-725
Proprietary Name: Triamterene and Hydrochlorothiazide
Non Proprietary Name: Triamterene and Hydrochlorothiazide
Active Ingredient(s): 25; 50    mg/1; mg/1 & nbsp;   Triamterene and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Triamterene and Hydrochlorothiazide

Product NDC: 55289-725
Labeler Name: PD-Rx Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA073191
Marketing Category: ANDA
Start Marketing Date: 19910731

Package Information of Triamterene and Hydrochlorothiazide

Package NDC: 55289-725-30
Package Description: 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-725-30)

NDC Information of Triamterene and Hydrochlorothiazide

NDC Code 55289-725-30
Proprietary Name Triamterene and Hydrochlorothiazide
Package Description 30 CAPSULE in 1 BOTTLE, PLASTIC (55289-725-30)
Product NDC 55289-725
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Triamterene and Hydrochlorothiazide
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 19910731
Marketing Category Name ANDA
Labeler Name PD-Rx Pharmaceuticals, Inc.
Substance Name HYDROCHLOROTHIAZIDE; TRIAMTERENE
Strength Number 25; 50
Strength Unit mg/1; mg/1
Pharmaceutical Classes Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Triamterene and Hydrochlorothiazide


General Information